Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Bayer Q3 2026 Sales Reach €10.053 Billion as Pharmaceuticals Division Hits Growth Turning Point – Nubeqa and Kerendia Lead the Rebound
Company

Bayer Q3 2026 Sales Reach €10.053 Billion as Pharmaceuticals Division Hits Growth Turning Point – Nubeqa and Kerendia Lead the Rebound

Bayer AG (ETR: BAYN) reported its third‑quarter 2026 financial results, with group sales of €10.053 billion, up 4.1 % year‑on‑year (+1.9 % currency‑ and portfolio‑adjusted), as the Pharmaceuticals Division reached…

Boehringer Ingelheim Launches AIRWARD Phase III Trial of Verducatib – First Oral DPP1 Inhibitor to Reach Phase III in COPD

Boehringer Ingelheim Launches AIRWARD Phase III Trial of Verducatib – First Oral DPP1 Inhibitor to Reach Phase III in COPD

Lynk Pharmaceuticals Expands Commercialization Partnership with Simcere – Exclusive Greater China Rights for Zemprocitinib Extended to Atopic Dermatitis and Dermatological Indications

Lynk Pharmaceuticals Expands Commercialization Partnership with Simcere – Exclusive Greater China Rights for Zemprocitinib Extended to Atopic Dermatitis and Dermatological Indications

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Shanghai Yizhong’s Paclitaxel Micelles Data to be Presented at ASCO Annual Meeting

CompanyDrug

Ascentage Pharma to Present Clinical Results of Four Oncology Drugs at Medical Conference

CompanyDrug

BeiGene Presents Groundbreaking Clinical Data at ASCO Annual Meeting

CompanyDrug

Chia Tai Tianqing’s TQ-B3525 Heads for Priority Review for Recurrent Follicular Lymphoma

CompanyDrug

GenScript’s Legend Biotech Files Type II Variation Application for Carvykti with EMA

CompanyDrug

Takeda and HutchMed’s Fruquintinib Receives Priority Review Status from FDA

CompanyDrug

Sichuan Kelun Pharmaceutical to Present Clinical Data on RET Inhibitor and ADC at ASCO

Policy / RegulatoryR&D

Lancet Study Reveals Dalian’s Cancer Survival Rates Compared to US

Show More